Produkty 638-95-9

CAS 638-95-9 występuje w naszej ofercie pod nazwami: Alpha-Amyrin, >95% (HPLC), alfa-Amyrin, Alpha-Amyrin/ 98.14% (existing batch purity), α–Amyrin, α-Amyrin. Oferty producentów: TRC, Chemat Brand, TargetMol, GLPBio, Biosynth. Dostępne opakowania: 1mg, on request, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg.

Alpha-Amyrin, >95% (HPLC)
TRC
  • opakowanie: 1mg
  • Warianty: 1
Zobacz produkt
alfa-Amyrin
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Alpha-Amyrin/ 98.14% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 5
od 1009,99
Zobacz produkt
α–Amyrin
GLPBio
  • opakowanie: 1mg, 10mg, 5mg
  • Warianty: 3
od 751,50
Zobacz produkt
α-Amyrin
Biosynth
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
ALPHA-AMYRIN
Sigma-Aldrich
  • opakowanie: 10MG
  • Warianty: 1
od 1582,00
Zobacz produkt
α-Amyrin, 97%, 97%
Chemat
  • opakowanie: 2mg, 5mg, 10mg, 100mg
  • Warianty: 5
od 122,00
Zobacz produkt
α-Amyrin (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
α-Amyrin, 99.99%
MedChemExpress
  • opakowanie: 5 mg, 1 mg, 10 mg
  • Warianty: 3
od 505,45
Zobacz produkt
alpha-Amyrin, ROTICHROM® HPLC, 10 mg, glass
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 1505,56
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol (CAS 638-95-9) to związek chemiczny o wzorze sumarycznym C30H50O i masie molowej 426.7 g/mol. Nazwa systematyczna IUPAC: (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol. InChIKey: FSLPMRQHCOLESF-SFMCKYFRSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H50O
Masa molowa426.7 g/mol
Nazwa IUPAC(3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol
InChIKeyFSLPMRQHCOLESF-SFMCKYFRSA-N
SMILESC[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: alpha-Amyrin, Viminalol, alpha-Amyrine, 5alpha-urs-12-en-3beta-ol, (3beta)-urs-12-en-3-ol, Urs-12-en-3beta-ol, a-amyrin, .alpha.-Amyrenol, (3.beta.)-Urs-12-en-3-ol, alfa-Amyrin
Powiązane formy tego związku
(3R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol C30H50O
Izomery (ten sam wzór sumaryczny)
(3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol C30H50O
(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol C30H50O
(3S,8R,9R,10S,13R,14S,17R)-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O
(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C30H50O
(3S)-2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane C30H50O
(3S,4aR,6aR,6aR,6bR,8aR,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-hexadecahydropicen-3-ol C30H50O
(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecan-6-ol C30H50O
2,2-dimethyl-3-[(3E,7E,11E,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane C30H50O
(4R,4aS,6aS,6aS,6bR,8aR,12aR,14aS,14bS)-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1H-picen-3-one C30H50O
(3R,6aS,6aS,6bR,8aR,12aR,14aR,14bS)-4,4,6a,6b,8a,11,11,14a-octamethyl-1,2,3,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydropicen-3-ol C30H50O
(3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C30H50O